India Parkinson's Disease Diagnosis and Treatment Market Statistics (2026 - 2035)

The India Parkinson’s disease diagnosis and treatment market is expected to increase from USD 299.6 million in 2025 to USD 881.85 million by 2035, growing at a CAGR of 11.4% throughout the forecast period from 2026 to 2035.

Key Takeaways

• The global Parkinsons disease diagnosis and treatment market is forecast to increase from USD 8.16 billion in 2026 to USD 17.57 billion by 2035, with a CAGR of 8.9%.
• North America held a major revenue share of the market by 39% in 2025.
• Asia-Pacific is expected to host the fastest-growing market by 10.3% CAGR in the coming years.
• By diagnosis, the imaging tests segment contributed the biggest revenue share of the market in 2025 and is expected to witness the fastest growth in the market over the forecast period.
• By treatment, the medications segment held the largest revenue share of the market in 2025.
• By treatment, the deep brain stimulation segment is expected to grow with the highest CAGR in the market during the studied years.

Parkinson's Disease Diagnosis and Treatment Market Overview

"According to Parkinson’s News Today, about 41 out of every 100,000 people in their 40s are affected by Parkinson’s disease. This number increases to more than 1,900 out of every 100,000 for people in their 80s and 90s. Parkinson's is the second most common neurodegenerative disorder, after Alzheimer’s disease. Right now, there's no cure for Parkinson's, and people with the condition need lifelong medication support."

Parkinson's disease is a neurological disorder characterized by involuntary movements such as tremors, stiffness, and difficulty with coordination. Symptoms usually develop gradually and worsen over time, affecting mobility, speech, and cognition. While the exact cause is unclear, research suggests a combination of genetic and environmental factors may contribute to the disease's onset. Parkinson's primarily affects the basal ganglia in the brain, leading to a decrease in dopamine production and subsequent movement problems. Despite ongoing research, the exact reasons for nerve cell death in Parkinson's remain unknown.

Parkinson's has four major symptoms:

• Tremors in the arms, legs, jaw or hands, head
• Muscle stiffness
• The slow movement
• Diminished balance and coordination, can lead to falls

Parkinson's Disease Diagnosis and Treatment Market Companies

• Siemens Healthineers AG
• Abbott Laboratories
• General Electric Company
• AbbVie
• Merck & Co.
• Pfizer
• Teva Pharmaceutical Industries Ltd.
• Sun Pharma
• Novartis AG
• Cerevel Therapeutics

Parkinson's Disease Diagnosis and Treatment Market Segments

By Diagnosis

• Imaging Tests
• Blood Tests
• Other Tests

By Treatment

• Medications 
  • Carbidopa-levodopa
  • Dopamine Agonists
  • MAO-B Inhibitors
  • COMT Inhibitors
  • Anticholinergics
  • Others
• Deep Brain Stimulation
• Other Treatments